Characteristics and short-term outcomes of neonates with mild hypoxic-ischemic encephalopathy treated with hypothermia
Por um escritor misterioso
Descrição
PDF) Magnetic Resonance Biomarkers and Neurological Outcome of Infants with Mild Hypoxic-Ischaemic Encephalopathy Who Progress to Moderate Hypoxic-Ischaemic Encephalopathy
Randomized Controlled Trial Evaluating Hypothermia for Neonatal Encephalopathy in Low- and Middle-Income Countries
Frontiers Therapeutic Hypothermia for Neonatal Hypoxic–Ischemic Encephalopathy – Where to from Here?
Association of EEG Background and Neurodevelopmental Outcome in Neonates With Hypoxic-Ischemic Encephalopathy Receiving Hypothermia
Frontiers Current Therapies for Neonatal Hypoxic–Ischaemic and Infection-Sensitised Hypoxic–Ischaemic Brain Damage
Hypothermia for moderate or severe neonatal encephalopathy in low-income and middle-income countries (HELIX): a randomised controlled trial in India, Sri Lanka, and Bangladesh - The Lancet Global Health
Therapeutic Hypothermia Effects on Brain Development - Practical Neurology
Update of hie treatment
Association of cerebral metabolic rate following therapeutic hypothermia with 18-month neurodevelopmental outcomes after neonatal hypoxic ischemic encephalopathy - eBioMedicine
PDF) Cooling neonates who do not fulfil the standard cooling criteria - short- and long-term outcomes
Trial of Erythropoietin for Hypoxic–Ischemic Encephalopathy in Newborns